drug

Cognitive Behavior Treatment

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Dartmouth-Hitchcock Medical Center
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses
NCT00053690—Completed

KOLs & investigators

2
Stanley Rosenberg, Ph.D.
Kim Mueser, Ph.D.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Dartmouth-Hitchcock Medical Center
company
trial
Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses
NA
trial
indication
Schizophrenia
indication
Depression
indication
Bipolar Disorder
indication
Stress Disorders, Post-Traumatic
indication
KOL
Stanley Rosenberg, Ph.D.
KOL score —
person
Kim Mueser, Ph.D.
KOL score —
person